ALKS
Price
$29.49
Change
-$0.26 (-0.87%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
4.55B
26 days until earnings call
PBH
Price
$78.56
Change
+$0.28 (+0.36%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
3.6B
19 days until earnings call
Ad is loading...

ALKS vs PBH

Header iconALKS vs PBH Comparison
Open Charts ALKS vs PBHBanner chart's image
Alkermes
Price$29.49
Change-$0.26 (-0.87%)
Volume$17.56K
Capitalization4.55B
Prestige Consumer Healthcare
Price$78.56
Change+$0.28 (+0.36%)
Volume$1.88K
Capitalization3.6B
ALKS vs PBH Comparison Chart
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. PBH commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Hold and PBH is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (ALKS: $29.75 vs. PBH: $78.28)
Brand notoriety: ALKS and PBH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 146% vs. PBH: 117%
Market capitalization -- ALKS: $4.55B vs. PBH: $3.6B
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. PBH’s [@Pharmaceuticals: Other] market capitalization is $3.6B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 1 FA rating(s) are green whilePBH’s FA Score has 1 green FA rating(s).

  • ALKS’s FA Score: 1 green, 4 red.
  • PBH’s FA Score: 1 green, 4 red.
According to our system of comparison, PBH is a better buy in the long-term than ALKS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 4 TA indicator(s) are bullish while PBH’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 4 bullish, 4 bearish.
  • PBH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PBH is a better buy in the short-term than ALKS.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а +4.68% price change this week, while PBH (@Pharmaceuticals: Other) price change was +5.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.37%. For the same industry, the average monthly price growth was +2.59%, and the average quarterly price growth was -9.58%.

Reported Earning Dates

ALKS is expected to report earnings on Apr 23, 2025.

PBH is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.37% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALKS($4.55B) has a higher market cap than PBH($3.6B). PBH has higher P/E ratio than ALKS: PBH (14.90) vs ALKS (8.90). ALKS YTD gains are higher at: 3.442 vs. PBH (0.243). ALKS has higher annual earnings (EBITDA): 519M vs. PBH (10.8M). ALKS has more cash in the bank: 773M vs. PBH (63.6M). ALKS has less debt than PBH: ALKS (372M) vs PBH (1.21B). ALKS has higher revenues than PBH: ALKS (1.66B) vs PBH (1.13B).
ALKSPBHALKS / PBH
Capitalization4.55B3.6B126%
EBITDA519M10.8M4,806%
Gain YTD3.4420.2431,415%
P/E Ratio8.9014.9060%
Revenue1.66B1.13B147%
Total Cash773M63.6M1,215%
Total Debt372M1.21B31%
FUNDAMENTALS RATINGS
ALKS vs PBH: Fundamental Ratings
ALKS
PBH
OUTLOOK RATING
1..100
6360
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
3110
SMR RATING
1..100
3961
PRICE GROWTH RATING
1..100
5048
P/E GROWTH RATING
1..100
9234
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBH's Valuation (75) in the Pharmaceuticals Other industry is in the same range as ALKS (94) in the Biotechnology industry. This means that PBH’s stock grew similarly to ALKS’s over the last 12 months.

PBH's Profit vs Risk Rating (10) in the Pharmaceuticals Other industry is in the same range as ALKS (31) in the Biotechnology industry. This means that PBH’s stock grew similarly to ALKS’s over the last 12 months.

ALKS's SMR Rating (39) in the Biotechnology industry is in the same range as PBH (61) in the Pharmaceuticals Other industry. This means that ALKS’s stock grew similarly to PBH’s over the last 12 months.

PBH's Price Growth Rating (48) in the Pharmaceuticals Other industry is in the same range as ALKS (50) in the Biotechnology industry. This means that PBH’s stock grew similarly to ALKS’s over the last 12 months.

PBH's P/E Growth Rating (34) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALKS (92) in the Biotechnology industry. This means that PBH’s stock grew somewhat faster than ALKS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSPBH
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
67%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
47%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
60%
Declines
ODDS (%)
Bearish Trend 8 days ago
62%
Bearish Trend 11 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
75%
Aroon
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
40%
View a ticker or compare two or three
Ad is loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with VTRS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
+2.41%
VTRS - ALKS
34%
Loosely correlated
-0.44%
COLL - ALKS
28%
Poorly correlated
+1.52%
PAHC - ALKS
26%
Poorly correlated
+0.34%
AMPH - ALKS
26%
Poorly correlated
-1.60%
ESPR - ALKS
25%
Poorly correlated
+2.26%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+1.40%
PAHC - PBH
33%
Loosely correlated
+0.34%
VTRS - PBH
29%
Poorly correlated
-0.44%
SUPN - PBH
27%
Poorly correlated
-1.15%
APNHF - PBH
26%
Poorly correlated
N/A
ALKS - PBH
25%
Poorly correlated
+2.41%
More